Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

BACKGROUND: The current use of targeted therapy plus neoadjuvant chemotherapy for inflammatory breast cancer (IBC) is based on data extrapolated from studies in non-IBC. We conducted a systematic review to determine whether neoadjuvant chemotherapy plus targeted therapy results in a higher pathologi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Chainitikun, Sudpreeda, Espinosa Fernandez, Jose Rodrigo, Long, James P., Iwase, Toshiaki, Kida, Kumiko, Wang, Xiaoping, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8051801/
https://ncbi.nlm.nih.gov/pubmed/33861773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0250057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados